Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106 USD | +0.06% | -1.39% | -3.67% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.67% | 184B | |
-0.77% | 107B | |
-2.98% | 69.44B | |
+3.93% | 50.37B | |
+8.93% | 44.82B | |
+3.40% | 41.53B | |
+3.11% | 26.84B | |
+3.78% | 26.73B | |
+15.23% | 25.71B | |
-0.38% | 24.34B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Evercore ISI Adjusts Abbott Laboratories Price Target to $106 From $110, Maintains Outperform Rating